Zimbabwe has declined a major US healthcare agreement valued at $367m (£272m) over five years due to Washington's insistence on sensitive biological samples.
This rejection was revealed after a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
A government spokesperson has since clarified that the US was demanding access to biological samples for research and profit but was unwilling to share the benefits from future medical innovations.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for continued negotiations to find a deal agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.
Broader Implications
This development follows a comparable situation in neighbouring Kenya, where a court halted a related health funding agreement following concerns were filed about the safety of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump claimed its spending was "inefficient" and his administration was seeking government-to-government agreements to enhance openness and responsibility.
According to statements, Sixteen nations in Africa have so far signed these new agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Deal
This assistance for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to share its biological resources and data over an extended period, with no corresponding assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Effectively, our country would provide the raw materials for medical research with no certainty that the final treatments would be available to our people should a future health crisis arise."
National Interest and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were upending structures already set up through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to manage potential pandemics.
"This system is intended to ensure that when a country provides its data, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to develop them."
The government's concerns over the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how subsequent co-operation could be structured in a manner that honours the independence and dignity of both nations."
Medical Community Reaction
A leading public health body expressed it recognised the government's concerns, but urged that talks need to persist given that a large portion of the nation's HIV programmes depended on foreign aid.
"If specific concerns arise, including those relating to information security or agreement terms, these can often be resolved via detailed discussion and mutually agreed protections," it added.
The halted deal emphasises the ongoing tensions between accepting vital foreign assistance and safeguarding local interests in an increasingly interconnected world.